#RNAinterference drug developer #SanegeneBio leads our round-up of this week's #biotechfinancings, with a $110 million Series B backed by recent partner #EliLilly.
pharmaphorum.com/news/sanegen...
0
0
0
0
#RNAinterference drug developer #SanegeneBio leads our round-up of this week's #biotechfinancings, with a $110 million Series B backed by recent partner #EliLilly.
pharmaphorum.com/news/sanegen...